相关实验视频
Updated: Feb 28, 2026

06:40
The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
7.1K
临床证据将肠道微生物组与功能性消化不良联系起来:系统性审查和元分析
Kyungjae Lee1, Hojun Kim2, Jing-Hua Wang3
1College of Korean Medicine, Dongguk University, 32 Dongguk-ro, Ilsandong-gu, Goyang-si 10326, Gyeonggi-do, Republic of Korea.
Biomedicines
|February 27, 2026
概括
功能性消化不良 (FD) 在患者和对照人群之间没有显著的肠道微生物群差异. 然而,干预措施通过改变肠道微生物群体和增加短链脂肪酸 (SCFA) 来改善症状.
科学领域:
- 胃肠病学 胃肠病学
- 微生物组研究 微生物组研究
- 代谢学 代谢学 代谢学
背景情况:
- 肠道微生物组越来越多地与功能性消化不良 (FD) 有关.
- 肠道微生物群和FD病理生理学的确切关系尚不清楚.
- 这项研究系统地审查和元分析了肠道微生物组在FD中的作用.
研究的目的:
- 研究肠道微生物组在功能性消化不良 (FD) 中的作用.
- 分析FD患者和健康个体之间的肠道微生物群的差异.
- 评估干预措施对FD肠道微生物群的影响.
主要方法:
- 在PubMed,谷歌学者和科学网上进行了系统的文献搜索.
- 包括到2025年9月发表的17项临床研究 (8项观察性,9项干预性).
- 用元分析合成了关于肠道微生物群和FD的数据.
主要成果:
- 在FD患者和健康对照者之间,没有发现肠道微生物群多样性 (α或β) 的显著差异.
- 这些干预措施导致微生物社区结构发生了重大变化.
- 这些微生物转变与短链脂肪酸 (SCFA) 产量增加和FD症状改善相关.
结论:
- 虽然基线肠道微生物群组成在FD中没有显著差异,但干预措施可以诱导实质性的微生物变化.
- 调节肠道微生物群及其代谢物,如SCFA,为FD管理提供了潜在的治疗途径.
相关概念视频
Assessment of the Gastrointestinal System I: Subjective Data
729
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
729
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
695
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
695
Peptic Ulcer Disease I: Introduction
933
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
933
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.3K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.3K
Irritable Bowel Syndrome I: Introduction
1.3K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.3K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
1.4K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.4K

